Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2681 |
|
| Actual shortage: | 250 (9%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 9 (0%) | |
| Resolved: | 2422 (90%) | |
Discontinuation Reports |
250 |
|
| To be discontinued: | 3 (1%) | |
| Discontinued: | 247 (99%) | |
| Reversed: | 0 (0%) | |
Late reports |
330 (11%) |
|
Overdue reports |
25 (10%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| ACT CIPROFLOXACIN | 500MG | TABLET | Resolved | 2018-12-04 | 2019-03-12 | 68599 |
| ACT DILTIAZEM CD | Actual shortage | 2018-12-04 | 2018-12-04 | 68602 | ||
| ACT LEVOFLOXACIN | 750MG | TABLET | Resolved | 2018-12-04 | 2019-08-16 | 68605 |
| EPIRUBICIN FOR INJECTION | 2MG | SOLUTION | Resolved | 2018-12-04 | 2019-08-06 | 68608 |
| TEVA-IRBESARTAN | 75MG | TABLET | Resolved | 2018-12-04 | 2019-06-03 | 68616 |
| TEVA-IRBESARTAN HCTZ | 12.5MG 150MG | TABLET | Resolved | 2018-12-04 | 2019-04-11 | 68619 |
| TEVA-IRBESARTAN HCTZ | 12.5MG 300MG | TABLET | Resolved | 2018-12-04 | 2019-04-11 | 68622 |
| ETOPOSIDE INJECTION | 20MG | LIQUID | Resolved | 2018-12-04 | 2020-03-16 | 68626 |
| ETOPOSIDE INJECTION | 20MG | LIQUID | Resolved | 2018-12-04 | 2020-03-16 | 68629 |
| ETOPOSIDE INJECTION | 20MG | LIQUID | Resolved | 2018-12-04 | 2020-03-16 | 68632 |
| TEVA-FLUVASTATIN | 20MG | CAPSULE | Resolved | 2019-01-08 | 2020-04-02 | 71550 |
| TEVA-FLUVASTATIN | 40MG | CAPSULE | Resolved | 2019-01-08 | 2020-03-19 | 71553 |
| FLUDARABINE PHOSPHATE FOR INJECTION | 25MG | SOLUTION | Resolved | 2019-02-05 | 2019-03-12 | 74792 |
| TEVA-DILTIAZEM CD | 180MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2019-04-11 | 2019-06-03 | 81415 |
| TEVA-CARBAMAZEPINE | 200MG | TABLET | Resolved | 2019-04-25 | 2019-05-28 | 82410 |
| ACT DILTIAZEM CD | 120MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2019-04-26 | 2021-05-26 | 82552 |
| ACT DILTIAZEM CD | 180MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2019-04-26 | 2021-05-26 | 82555 |
| FLUDARABINE PHOSPHATE FOR INJECTION | 25MG | SOLUTION | Resolved | 2019-06-03 | 2019-08-07 | 85468 |
| TEVA-CLOPIDOGREL | 75MG | TABLET | Resolved | 2019-06-13 | 2019-07-15 | 86599 |
| LEUCOVORIN CALCIUM INJECTION | 10MG | SOLUTION | Resolved | 2019-06-13 | 2019-08-21 | 86601 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-ROSUVASTATIN | 5MG | TABLET | Discontinued | 2022-03-25 | 2022-03-26 | 157428 |
| TEVA-ROSUVASTATIN | 10MG | TABLET | Discontinued | 2022-03-25 | 2022-03-26 | 157431 |
| TEVA-ROSUVASTATIN | 20MG | TABLET | Discontinued | 2022-03-25 | 2022-03-26 | 157434 |
| TEVA-ROSUVASTATIN | 40MG | TABLET | Discontinued | 2022-03-25 | 2022-03-26 | 157437 |
| PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION | 0.375G 3G | POWDER FOR SOLUTION | Discontinued | 2023-11-15 | 2023-11-15 | 210191 |
| PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION | 0.5G 4G | POWDER FOR SOLUTION | Discontinued | 2023-11-15 | 2023-11-15 | 210194 |
| CEFAZOLIN FOR INJECTION | 10G | POWDER FOR SOLUTION | Discontinued | 2023-11-27 | 2023-11-27 | 211558 |
| TEVA-ECTOSONE | 0.1% | LOTION | Discontinued | 2023-12-05 | 2023-12-05 | 212526 |
| TEVA-DICLOFENAC EC | 25MG | TABLET (ENTERIC-COATED) | Discontinued | 2024-01-25 | 2024-01-26 | 217254 |
| TEVA-IRBESARTAN | 75MG | TABLET | Discontinued | 2024-04-01 | 2024-04-01 | 224049 |